These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7873531)

  • 21. High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite.
    Borgna JL; Rochefort H
    Mol Cell Endocrinol; 1980 Oct; 20(1):71-85. PubMed ID: 7439523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B; Happe HK
    Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen receptor binding to DNA: affinity for nonpalindromic elements from the rat prolactin gene.
    Murdoch FE; Byrne LM; Ariazi EA; Furlow JD; Meier DA; Gorski J
    Biochemistry; 1995 Jul; 34(28):9144-50. PubMed ID: 7619813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uterine estrogen receptor interaction with estrogen-responsive DNA sequences in vitro: effects of ligand binding on receptor-DNA complexes.
    Curtis SW; Korach KS
    Mol Endocrinol; 1990 Feb; 4(2):276-86. PubMed ID: 2330006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor-induced DNA bending: orientation of the bend and replacement of an estrogen response element with an intrinsic DNA bending sequence.
    Nardulli AM; Grobner C; Cotter D
    Mol Endocrinol; 1995 Aug; 9(8):1064-76. PubMed ID: 7476980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of tetrahydrocrysene ketone with estrogen receptors alpha and beta indicates conformational differences in the receptor subtypes.
    Tyulmenkov VV; Klinge CM
    Arch Biochem Biophys; 2000 Sep; 381(1):135-42. PubMed ID: 11019829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen response element sequence impacts the conformation and transcriptional activity of estrogen receptor alpha.
    Klinge CM; Jernigan SC; Smith SL; Tyulmenkov VV; Kulakosky PC
    Mol Cell Endocrinol; 2001 Mar; 174(1-2):151-66. PubMed ID: 11306182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining a minimal estrogen receptor DNA binding domain.
    Mader S; Chambon P; White JH
    Nucleic Acids Res; 1993 Mar; 21(5):1125-32. PubMed ID: 8385312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: studies using human estrogen receptor overexpressed in mammalian cells.
    Reese JC; Katzenellenbogen BS
    Nucleic Acids Res; 1991 Dec; 19(23):6595-602. PubMed ID: 1754396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uterine estrogen receptor-DNA complexes: effects of different ERE sequences, ligands, and receptor forms.
    Curtis SW; Korach KS
    Mol Endocrinol; 1991 Jul; 5(7):959-66. PubMed ID: 1944301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The two native estrogen receptor forms of 8S and 4S present in cytosol from human uterine tissues display opposite reactivities with the antiestrogen tamoxifen aziridine and the estrogen responsive element.
    Navarro D; León L; Chirino R; Fernández L; Pestano J; Díaz-Chico BN
    J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):49-58. PubMed ID: 9569010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor.
    Pakdel F; Reese JC; Katzenellenbogen BS
    Mol Endocrinol; 1993 Nov; 7(11):1408-17. PubMed ID: 8114756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of estrogen-responsive element- and ligand-induced structural changes on the recruitment of cofactors and transcriptional responses by ER alpha and ER beta.
    Yi P; Driscoll MD; Huang J; Bhagat S; Hilf R; Bambara RA; Muyan M
    Mol Endocrinol; 2002 Apr; 16(4):674-93. PubMed ID: 11923465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
    Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
    J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity.
    Fan JD; Wagner BL; McDonnell DP
    Mol Endocrinol; 1996 Dec; 10(12):1605-16. PubMed ID: 8961270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
    Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
    Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An estrogen-responsive element-targeted histone deacetylase enzyme has an antiestrogen activity that differs from that of hydroxytamoxifen.
    Demirpence E; Semlali A; Oliva J; Balaguer P; Badia E; Duchesne MJ; Nicolas JC; Pons M
    Cancer Res; 2002 Nov; 62(22):6519-28. PubMed ID: 12438246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
    Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of an estrogen-responsive element binding protein repressed by estradiol.
    Gray WG; Gorski J
    Biochemistry; 1996 Sep; 35(36):11685-92. PubMed ID: 8794749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo.
    Metzger D; Berry M; Ali S; Chambon P
    Mol Endocrinol; 1995 May; 9(5):579-91. PubMed ID: 7565805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.